{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-122661","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2022-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.111470+00:00","generated_at":"2026-06-21T12:16:48.949276+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"AbbVie CFO promoted to EVP; Controller Durkin to retire, Buckbee named successor","bullets":["Scott T. Reents, previously Senior VP/CFO, appointed Executive Vice President, CFO effective immediately.","Brian L. Durkin, VP Controller, plans to retire effective March 1, 2023.","Kevin K. Buckbee, 57, appointed Senior VP Controller effective March 1, 2023; previously VP Controller, Global Commercial Ops since Jan 2016."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-122661","json":"https://secwatch.observer/filing/0001104659-22-122661.json","markdown":"https://secwatch.observer/filing/0001104659-22-122661.md","text":"https://secwatch.observer/filing/0001104659-22-122661.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/0001104659-22-122661-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/tm2231449d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:16:48.949276+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f4cc9033a","claim":"Kevin K. Buckbee was appointed as Senior Vice President, Controller at AbbVie Inc..","evidence_excerpt":"Kevin K. Buckbee, 57, has been appointed Senior Vice President, Controller effective March 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/0001104659-22-122661-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Controller"}],"fact_type":"executive_change"},{"claim_id":"5a9246b0ec","claim":"Brian L. Durkin departed as Vice President, Controller at AbbVie Inc..","evidence_excerpt":"On November 28, 2022, Brian L. Durkin, Vice President, Controller, informed AbbVie that he plans to retire from the Controller role effective March 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/0001104659-22-122661-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Vice President, Controller"}],"fact_type":"executive_change"},{"claim_id":"8b02c55ad5","claim":"Scott T. Reents was appointed as Executive Vice President, Chief Financial Officer at AbbVie Inc..","evidence_excerpt":"Scott T. Reents, Senior Vice President, Chief Financial Officer, has been appointed Executive Vice President, Chief Financial Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465922122661/0001104659-22-122661-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}